|
|
|
|
|
|
|
|
|
|
|
|
|
08.07.26 - 07:03
|
Antin Infrastructure Partners: Francisco Cabeza and Maximilian Lindner Promoted to Senior Partner (Business Wire)
|
|
|
PARIS & LONDON & NEW YORK--(BUSINESS WIRE)--Regulatory News:
Antin Infrastructure Partners (Paris:ANTIN) announces it is strengthening its Senior Partner ranks with the promotions of Francisco Cabeza and Maximilian Lindner, effective immediately. The appointments bring to 10 the number of Antin Senior Partners.
Both Mr. Cabeza and Mr. Lindner are London-based, and their appointments will further reinforce the office's senior leadership team, alongside Senior Partner and Office Head Simon Söder, as Antin enters a new fundraising cycle.
Mr. Cabeza joined Antin in 2022 as a Partner in London with more than 20 years' experience in the financial sector, including 11 years in Goldman Sachs' Investment Banking division, where he reached the level of Managing Director and head of Iberian M&A, and prior experience at DWS Infrastructure and ACS Iridium Infrastructure. He holds engineering degrees from Universidad Politécnica de Madrid and Ecole Nationale des Ponts et Chaussées - ParisTech and also holds an MB...
|
|
|
|
|
07.07.26 - 20:48
|
Goldman’s Top Strategist Sees a Dangerous Amount of Leverage Piling Up (24/7 Wall St.)
|
|
|
Ben Snider, Chief U.S. Equity Strategist at Goldman Sachs, went on CNBC to say something that should register with anyone who has been happily riding this market higher. The character of this market is shifting midyear, and the driver is a substantial increase in a substantial increase in leverage across investor types: retail margin debt, ... Goldman's Top Strategist Sees a Dangerous Amount of Leverage Piling Up...
|
|
|
|
|
07.07.26 - 17:12
|
SpaceX Joins Nasdaq 100; Crinetics Pharmaceuticals Soars on Buyout | Stock Movers (Bloomberg)
|
|
|
On this episode of Stock Movers:
- Fiserv (FISV) is climbing as the Wall Street Journal reports big banks including JPMorgan Chase, Bank of America, Wells Fargo and PNC Financial Services Group have held preliminary discussions about a deal to acquire a network owned by the financial-technology company Fiserv.
- Crinetics Pharmaceuticals (CRNC) is soaring after Vertex Pharmaceuticals agreed to buy Crinetics for $10 billion in cash to expand into endocrinology.
- SpaceX (SPCX) is lower even though at least six brokers, including Morgan Stanley and Goldman Sachs, have started coverage of SpaceX with buy-equivalent ratings. SpaceX's addition to the Nasdaq 100 should provide considerable support to the stock, considering the number of funds that track the tech-heavy benchmark. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
